KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Operating Leases (2019 - 2025)

Medpace Holdings' Operating Leases history spans 7 years, with the latest figure at $136.9 million for Q4 2025.

  • For Q4 2025, Operating Leases rose 8.41% year-over-year to $136.9 million; the TTM value through Dec 2025 reached $136.9 million, up 8.41%, while the annual FY2025 figure was $136.9 million, 8.41% up from the prior year.
  • Operating Leases reached $136.9 million in Q4 2025 per MEDP's latest filing, up from $119.1 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $164.5 million in Q4 2023 to a low of $112.8 million in Q2 2021.
  • Average Operating Leases over 5 years is $138.3 million, with a median of $136.5 million recorded in 2024.
  • Peak YoY movement for Operating Leases: skyrocketed 122.09% in 2021, then decreased 23.26% in 2024.
  • A 5-year view of Operating Leases shows it stood at $131.0 million in 2021, then increased by 20.75% to $158.1 million in 2022, then increased by 4.01% to $164.5 million in 2023, then fell by 23.26% to $126.2 million in 2024, then increased by 8.41% to $136.9 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Operating Leases are $136.9 million (Q4 2025), $119.1 million (Q3 2025), and $149.8 million (Q2 2025).